Emergent BioSolutions
EBS
#6261
Rank
ยฃ0.49 B
Marketcap
ยฃ9.11
Share price
7.00%
Change (1 day)
456.71%
Change (1 year)

Revenue for Emergent BioSolutions (EBS)

Revenue in 2024 (TTM): ยฃ0.85 Billion

According to Emergent BioSolutions 's latest financial reports the company's current revenue (TTM ) is ยฃ0.83 Billion. In 2023 the company made a revenue of ยฃ0.80 Billion a decrease over the revenue in the year 2022 that were of ยฃ0.89 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Emergent BioSolutions from 2004 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.85 B6.6%
2023 ยฃ0.80 B-10%
2022 ยฃ0.89 B-27.38%
2021 ยฃ1.22 B16.28%
2020 ยฃ1.05 B40.89%
2019 ยฃ0.75 B34.98%
2018 ยฃ0.55 B53.12%
2017 ยฃ0.36 B29.63%
2016 ยฃ0.27 B5.44%
2015 ยฃ0.26 B21.83%
2014 ยฃ0.21 B39.37%
2013 ยฃ0.15 B48.55%
2012 ยฃ0.10 B-40.16%
2011 ยฃ0.17 B-5.12%
2010 ยฃ0.18 B27.77%
2009 ยฃ0.14 B19.09%
2008 ยฃ0.12 B32.32%
2007 ยฃ92.07 M4.27%
2006 ยฃ88.3 M16.51%
2005 ยฃ75.78 M74.25%
2004 ยฃ43.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ48.35 B 5,715.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.13 B-83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.15 B 3,646.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ6.42 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ43.06 B 5,078.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.60 B 1,416.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
ยฃ0.09 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA